04 MAR

Autism breakthrough: Trial drug given ‘accelerated status’ paves way for faster approval

A POTENTIALLY “game changing” drug that tackles the root causes of autism could be available in the UK within five years, experts say. Initial trial results for Balovaptan has so impressed US regulators, it has been given “accelerated status”, paving the way for faster approval.

Post Author: martin

Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.